Thomas Chalberg
3 SlideShares 1 Seguidor
Personal Information
Organização/Local de trabalho
San Francisco, CA United States
Cargo
Founder and CEO
Setor
Consulting / Advisory
Site
thomaschalberg.com/
Sobre
An experienced biotechnology entrepreneur and the former Chief Executive Officer of Avalanche Biotechnologies, Inc., Thomas Chalberg has earned recognition as a biotechnology thought leader in Silicon Valley. Tom Chalberg co-founded Avalanche Biotechnologies, a gene therapy R&D company for ophthalmic conditions. He joined Avalanche as its first employee, and as CEO grew the company to more than 75 employees. As a technical expert in the gene therapy field, Thomas Chalberg is an author on a number of peer-reviewed publications in top journals, including The Lancet and Nature Biotechnology, and has served as Principal Investigator for a National Institutes of Health Small Business Innovatio
Detalhes do contato
Marcadores
thomas chalberg oncorus hope for vision foundation fighting blindness myopia macular degeneration cambridge biotech startups san francisco viruses cancer genetic markers aggressive brain cancer cancer immunotherapy patient expectations top 20 startups f biospace list 2017 fierce 15 forbes research cancer therapy aggressive cancers improve restore human sight rp drug retinal diseases biotechnology raising startup capital research initiatives aav vectors molecular structure
Ver mais

Apresentações

(3)

Research Initiatives Supported by the Foundation Fighting Blindness

Há 7 anos • 100 Visualizações

What Is Age-Related Macular Degeneration?

Há 6 anos • 128 Visualizações

Raising Awareness of Myopia, an Epidemic in the Making

Há 4 anos • 101 Visualizações
Personal Information
Organização/Local de trabalho
San Francisco, CA United States
Cargo
Founder and CEO
Setor
Consulting / Advisory
Site
thomaschalberg.com/
Sobre
An experienced biotechnology entrepreneur and the former Chief Executive Officer of Avalanche Biotechnologies, Inc., Thomas Chalberg has earned recognition as a biotechnology thought leader in Silicon Valley. Tom Chalberg co-founded Avalanche Biotechnologies, a gene therapy R&D company for ophthalmic conditions. He joined Avalanche as its first employee, and as CEO grew the company to more than 75 employees. As a technical expert in the gene therapy field, Thomas Chalberg is an author on a number of peer-reviewed publications in top journals, including The Lancet and Nature Biotechnology, and has served as Principal Investigator for a National Institutes of Health Small Business Innovatio
Marcadores
thomas chalberg oncorus hope for vision foundation fighting blindness myopia macular degeneration cambridge biotech startups san francisco viruses cancer genetic markers aggressive brain cancer cancer immunotherapy patient expectations top 20 startups f biospace list 2017 fierce 15 forbes research cancer therapy aggressive cancers improve restore human sight rp drug retinal diseases biotechnology raising startup capital research initiatives aav vectors molecular structure
Ver mais